Novartis Institutes for BioMedical Research Inc. 13D and 13G filings for Ayala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-10-31 4:00 pm Unchanged |
2022-10-19 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Novartis Institutes for BioMedical Research Inc. | 698,777 4.700% |
0 (Unchanged) |
Filing |
2021-02-05 5:17 pm Purchase |
2020-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Novartis Institutes for BioMedical Research Inc. | 698,777 5.500% |
698,777![]() (New Position) |
Filing |